Over the past 12 months, 0 insiders at Nabriva Therapeutics plc filed 0 open-market SEC Form 4 transactions on NBRV: 0 purchases worth $0 and 0 sales worth $0. Insiders have been mixed over this period. The most recent filing was on .
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 2, 22 | Daniel D BurgessDirector | SELL | 11.3K | $0.19 | $2K |
| Aug 2, 22 | Colin Md BroomDirector | SELL | 5.3K | $0.19 | $1K |
| Aug 2, 22 | Mark CorriganDirector | SELL | 10.3K | $0.19 | $2K |
| Aug 2, 22 | Stephen W WebsterDirector | SELL | 7.8K | $0.19 | $1K |
| Aug 1, 22 | Carrie L. BourdowDirector | SELL | 8.5K | $0.17 | $1K |
| Aug 1, 22 | Charles A Rowland JrDirector | SELL | 8.5K | $0.18 | $2K |
| Dec 28, 21 | Theodore R SchroederChief Executive Officer | BUY | 100.0K | $0.57 | $57K |
| Dec 27, 21 | J. Christopher NaftzgerGeneral Counsel and Corp Sec | BUY | 7.0K | $0.59 | $4K |
| Sep 14, 21 | Theodore R SchroederChief Executive Officer | BUY | 50.0K | $1.13 | $57K |
| Aug 2, 21 | Daniel D BurgessDirector | SELL | 1.1K | $1.20 | $1K |
| Aug 2, 21 | Carrie L. BourdowDirector | SELL | 777 | $1.20 | $932 |
| Aug 2, 21 | Colin Md BroomDirector | SELL | 531 | $1.20 | $637 |
| Aug 2, 21 | Charles A Rowland JrDirector | SELL | 777 | $1.20 | $932 |
| Aug 2, 21 | Stephen W WebsterDirector | SELL | 777 | $1.20 | $932 |
Over the past 12 months, insiders at Nabriva Therapeutics plc filed 0 open-market purchases worth $0 and 0 sales worth $0 on NBRV, which makes them mixed over the period. The most recent Form 4 was filed on .
The largest recent open-market NBRV insider purchase in our data was $57K by Theodore R Schroeder, Chief Executive Officer, filed on Dec 28, 21.
0 different insiders at Nabriva Therapeutics plc filed open-market SEC Form 4 transactions on NBRV over the last 12 months.
InsiderTape plots every NBRV insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Nabriva Therapeutics plc insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →